MBX Biosciences, Inc. (MBX)
34.79
-2.47
(-6.63%)
USD |
NASDAQ |
Feb 20, 16:00
34.12
-0.67
(-1.93%)
After-Hours: 20:00
MBX Biosciences Total Assets (Quarterly) : 400.08M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 199.21B |
| Madrigal Pharmaceuticals, Inc. | 1.260B |
| Insmed, Inc. | 2.265B |
| UnitedHealth Group, Inc. | 309.58B |
| Aardvark Therapeutics, Inc. | 133.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.54M |
| Shareholders Equity (Quarterly) | 387.54M |
| Debt to Equity Ratio | 0.0016 |
| Current Ratio | 32.95 |
| Net Debt Paydown Yield | -0.01% |